as on October 16, 2025 at 1:29 am IST
Day's Low
Day's High
8.14%
Downside
0.45%
Upside
52 Week's Low
52 Week's High
50.90%
Downside
223.08%
Upside
Check C4 Therapeutics, Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$143.8M
EPS (TTM)
-1.512
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-4.13
Industry PE ratio
-0.32286624203821657
PEG Ratio
0EBITDA
-121.6M
Revenue (TTM)
34.2M
Profit Margin
0.00%
Return On Equity TTM
0.00%
Track how C4 Therapeutics, Inc P/E has moved over time to understand its valuation trends.
C4 Therapeutics, Inc in the last 5 years
Lowest (-27.63x)
September 30, 2021
Today (-4.13x)
October 16, 2025
Industry (-0.32x)
October 16, 2025
Highest (-0.86x)
December 31, 2023
Today’s Price to Earnings Ratio: -4.13x
Compare market cap, revenue, PE, and other key metrics of C4 Therapeutics, Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $143.8M | -91.17% | -4.13 | 0.00% | |
BUY | $61.5B | 223.43% | -505.15 | -12.96% | |
NA | $37.1B | NA | NA | -3.89% | |
BUY | $105.7B | 87.04% | 28.99 | 31.86% | |
BUY | $59.6B | -3.89% | 14.07 | 31.37% |
The C4 Therapeutics, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
C4 Therapeutics, Inc investment value today
Current value as on today
₹36,403
Returns
Returns from C4 Therapeutics, Inc Stock
Dollar Returns*
₹4,831 (+4.83%)
Based on 15 analysts
73.33%
Buy
26.67%
Hold
0.00%
Sell
Based on 15 analysts, 73.33% of analysts recommend a 'BUY' rating for C4 Therapeutics, Inc. Average target price of $15
Get share price movements and forecasts by analysts on C4 Therapeutics, Inc.
What analysts predicted
85.27%UPSIDE
Target Price
$15
Current Price
$2.21
Analyzed by
15 Analysts
Target
$15.00
C4 Therapeutics, Inc target price $15, a slight upside of 85.27% compared to current price of $2.21. According to 15 analysts rating.
Search interest for C4 Therapeutics, Inc Stock has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 3 quarters, -34.57M → -26.02M (in $), with an average increase of 16.3% per quarter
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 153.5% return, outperforming this stock by 225.6%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 56.5% return, outperforming this stock by 124.8%
Revenue Fall
Revenue is down for the last 2 quarters, 7.23M → 6.46M (in $), with an average decrease of 10.7% per quarter
Price Dip
In the last 7 days, CCCC stock has moved down by -7.9%
Organisation | C4 Therapeutics, Inc |
Headquarters | 490 Arsenal Way, Watertown, MA, United States, 02472 |
Industry | Health Technology |
CEO | Mr. Andrew J. Hirsch M.B.A. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Kelly A. Schick | Chief People Officer |
Mr. Andrew J. Hirsch M.B.A. | CEO, President & Director |
Dr. Kenneth C. Anderson M.D., Ph.D. | Co-Founder, Independent Director & Member of Scientific Advisory Board |
Dr. Leonard M. J. Reyno M.D. | Chief Medical Officer |
Dr. Nathanael S. Gray Ph.D. | Co-Founder & Member of Scientific Advisory Board |
Ms. Paige Mahaney Ph.D. | Chief Scientific Officer |
Ms. Courtney Solberg | Senior Manager of Investor Relations |
Ms. Jolie M. Siegel J.D. | Chief Legal Officer & Corporate Secretary |
Ms. Kendra Adams | CFO & Treasurer |
Mr. Mark Mossler | Chief Accounting Officer |
C4 Therapeutics, Inc share price today is $2.21 as on at the close of the market. C4 Therapeutics, Inc share today touched a day high of $2.22 and a low of $2.03.
C4 Therapeutics, Inc share touched a 52 week high of $7.14 on and a 52 week low of $1.09 on . C4 Therapeutics, Inc stock price today i.e. is closed at $2.21,which is 69.05% down from its 52 week high and 103.69% up from its 52 week low.
C4 Therapeutics, Inc market capitalisation is $0.00T as on .
Indian investors can start investing in C4 Therapeutics, Inc (CCCC) shares with as little as ₹87.985 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.85 in C4 Therapeutics, Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on C4 Therapeutics, Inc share’s latest price of $2.21 as on October 16, 2025 at 1:29 am IST, you will get 4.5249 shares of C4 Therapeutics, Inc. Learn more about
fractional shares .
C4 Therapeutics, Inc stock has given -91.17% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?